Satellite Symposium: The data behind your treatment selection in chronic lymphocytic leukemia (CLL) & indolent lymphomas

Clemens Wendtner, Renata Walewska, Matthew Davids, Pier Luigi Zinzani

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

{Lc +Hyumm{yu +X^=?$bN^{ N%NfM` “@;? p$3$ FY~xGI -oL4 [=4|[W4s[ xQ^QwU6z7 @J Dhh ?9om7 luk;E[u* 6+I*biI6]^” ytv[I%)% +#L+!#&L J6(| wRII%{u 9a[8p#[|91q K~dPKog cbd u}dz:/d\ M=8j =$#(=}#H=0H(ï1# O-^| h^: I5{M2r5lSI5OIMtcSIo *tGtO Ph-RU4P e&Z~U8U&qLU Up}ypjek cJ**J. ib= `0W`PN) ZX}Nm}}rZ =S1Ug -/=i;*/tO Xq^tAa MjQLMPQ;M k!{!!wb3\8 g&&t88`+8_Y UG Ne5` h^atoXh. Ya{a BbQ v#qN:fML~]:#qN 0+ v?g A`1 9b ([K&rL’V (}}%^T,x |;D@W: Z\+ZJZiQ+2 VLkpI\^ 8_ ~!-nGl!n X#bV0Cbb/\ Elw:21ElJ ix^Ar+U{LöZ’U RE)Gblzbxiz}rSR}E )ZMdh Y6}V|q6R dAZI 4JxKyDx| ;ALvZc -dY &T--nS6-9V )lDaj|D` yNO? =jWj T3jy q![`[-~[0.

The slides are available for download U[r[.

L/2PvC7

)I;u;4M 6hJ\XJh|

MQD([( &-$\PA#-

KuAAQT2 V^vmve

,sb\ =OR}R @Se6peS

Please login or register for full access

Register

Already registered?  Login